173 related articles for article (PubMed ID: 32692101)
1. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
Sevelius JM; Poteat T; Luhur WE; Reisner SL; Meyer IH
J Acquir Immune Defic Syndr; 2020 Aug; 84(5):437-442. PubMed ID: 32692101
[TBL] [Abstract][Full Text] [Related]
2. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
[TBL] [Abstract][Full Text] [Related]
3. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
[TBL] [Abstract][Full Text] [Related]
4. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
[TBL] [Abstract][Full Text] [Related]
5. The Role of Social Support in HIV Testing and PrEP Awareness among Young Black Men and Transgender Women Who Have Sex with Men or Transgender Women.
Lelutiu-Weinberger C; Wilton L; Koblin BA; Hoover DR; Hirshfield S; Chiasson MA; Nandi V; Usher D; Frye V
J Urban Health; 2020 Oct; 97(5):715-727. PubMed ID: 31898199
[TBL] [Abstract][Full Text] [Related]
6. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
[TBL] [Abstract][Full Text] [Related]
7. Pre-exposure Prophylaxis Awareness and Use Among Transgender and Nonbinary Individuals in Canada.
Hallarn J; Scheim AI; Bauer GR
J Acquir Immune Defic Syndr; 2024 Aug; 96(4):341-349. PubMed ID: 38916428
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
[TBL] [Abstract][Full Text] [Related]
9. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
Klein A; Golub SA
AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
[TBL] [Abstract][Full Text] [Related]
10. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
[TBL] [Abstract][Full Text] [Related]
11. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
[TBL] [Abstract][Full Text] [Related]
12. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
[TBL] [Abstract][Full Text] [Related]
13. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
[TBL] [Abstract][Full Text] [Related]
15. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men.
Eaton LA; Kalichman SC; Price D; Finneran S; Allen A; Maksut J
AIDS Behav; 2017 May; 21(5):1236-1246. PubMed ID: 28108878
[TBL] [Abstract][Full Text] [Related]
16. Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
Morris E; Teplinskaya A; Olansky E; Rinderle JK; Chapin-Bardales J;
MMWR Suppl; 2024 Jan; 73(1):9-20. PubMed ID: 38261546
[TBL] [Abstract][Full Text] [Related]
17. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.
John SA; Sizemore KM; Jimenez RH; Jones SS; Petroll AE; Rendina HJ
JMIR Public Health Surveill; 2022 Dec; 8(12):e31237. PubMed ID: 36306518
[TBL] [Abstract][Full Text] [Related]
18. PrEP Uptake and Discontinuation Among a U.S. National Sample of Transgender Men and Women.
Zarwell M; John SA; Westmoreland D; Mirzayi C; Pantalone DW; Golub S; Nash D; Grov C
AIDS Behav; 2021 Apr; 25(4):1063-1071. PubMed ID: 33057893
[TBL] [Abstract][Full Text] [Related]
19. HIV Testing and Preexposure Prophylaxis Prescriptions Among U.S. Commercially Insured Transgender Men and Women, 2014 to 2021.
Huang YA; Radix A; Zhu W; Kimball AA; Olansky EJ; Hoover KW
Ann Intern Med; 2024 Jan; 177(1):12-17. PubMed ID: 38109739
[TBL] [Abstract][Full Text] [Related]
20. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
